Encefalopatia epatica (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Encefalopatia epatica" in Italian language version.

refsWebsite

Global rank Italian rank

24nih.gov

4^th place

9^th place

22doi.org

2^nd place

7^th place

9oadoi.org

799^th place

22^nd place

3archive.org

6^th place

8^th place

2archive.today

14^th place

11^th place

1jhep-elsevier.com

low place

1wiley.com

222^nd place

243^rd place

1gastrojournal.org

low place

1gov.

low place

1cochrane.org

7,609^th place

4,497^th place

archive.org

(EN) Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI, Current concepts in the assessment and treatment of hepatic encephalopathy, in QJM, vol. 103, n. 1, gennaio 2010, pp. 9–16, DOI:10.1093/qjmed/hcp152, PMID 19903725.
(EN) Sundaram V, Shaikh OS, Hepatic encephalopathy: pathophysiology and emerging therapies, in Med. Clin. North Am., vol. 93, n. 4, luglio 2009, pp. 819–36, vii, DOI:10.1016/j.mcna.2009.03.009, PMID 19577116.
(EN) Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R, Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, in Hepatology, vol. 45, n. 3, 2007, pp. 549-59, DOI:10.1002/hep.21533, PMID 17326150.

archive.today

(EN) Polson J, Lee WM, AASLD position paper: the management of acute liver failure, in Hepatology, vol. 41, n. 5, maggio 2005, pp. 1179–97, DOI:10.1002/hep.20703, PMID 15841455. URL consultato il 2 novembre 2013 (archiviato dall'url originale il 16 dicembre 2012).
(EN) Randolph C, Hilsabeck R, Kato A, et al., Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines, in Liver Int., vol. 29, n. 5, maggio 2009, pp. 629–35, DOI:10.1111/j.1478-3231.2009.02009.x, PMID 19302444. URL consultato il 2 novembre 2013 (archiviato dall'url originale il 10 dicembre 2012).

cochrane.org

(EN) Als-Nielsen B, Gluud L, Gluud C, Nonabsorbable disaccharides for hepatic encephalopathy, in Bodil Als-Nielsen (a cura di), Cochrane Database of Systematic Reviews, Cochrane Database Syst Rev, n. 2, 2004, pp. CD003044, DOI:10.1002/14651858.CD003044.pub2, PMID 15106187.

doi.org

dx.doi.org

(EN) Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI, Current concepts in the assessment and treatment of hepatic encephalopathy, in QJM, vol. 103, n. 1, gennaio 2010, pp. 9–16, DOI:10.1093/qjmed/hcp152, PMID 19903725.
(EN) Polson J, Lee WM, AASLD position paper: the management of acute liver failure, in Hepatology, vol. 41, n. 5, maggio 2005, pp. 1179–97, DOI:10.1002/hep.20703, PMID 15841455. URL consultato il 2 novembre 2013 (archiviato dall'url originale il 16 dicembre 2012).
(EN) Bajaj JS, Review article: the modern management of hepatic encephalopathy, in Aliment. Pharmacol. Ther., vol. 31, n. 5, marzo 2010, pp. 537–47, DOI:10.1111/j.1365-2036.2009.04211.x, PMID 20002027.
(EN) Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H, Neuropsychological characterization of hepatic encephalopathy, in J. Hepatol., vol. 34, n. 5, maggio 2001, pp. 768–73, DOI:10.1016/S0168-8278(01)00026-5, PMID 11434627.
(EN) Sherlock S, Summerskill WH, White LP, Phear EA, Portal-systemic encephalopathy; neurological complications of liver disease, in Lancet, vol. 264, n. 6836, settembre 1954, pp. 453–7, DOI:10.1016/S0140-6736(54)91874-7, PMID 13193045.
(EN) Last PM, Sherlock S, Systemic absorption of orally administered neomycin in liver disease, in N. Engl. J. Med., vol. 262, n. 8, febbraio 1960, pp. 385–9, DOI:10.1056/NEJM196002252620803, PMID 14414396.
(EN) Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A, Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998, in Hepatology, vol. 35, n. 3, 2002, pp. 716–21, DOI:10.1053/jhep.2002.31250, PMID 11870389.
(EN) Sundaram V, Shaikh OS, Hepatic encephalopathy: pathophysiology and emerging therapies, in Med. Clin. North Am., vol. 93, n. 4, luglio 2009, pp. 819–36, vii, DOI:10.1016/j.mcna.2009.03.009, PMID 19577116.
(EN) Khan S, Tudur Smith C, Williamson P, Sutton R, Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis, in Saboor A Khan (a cura di), Cochrane Database of Systematic Reviews, Cochrane Database Syst Rev, n. 4, 2006, pp. CD000553, DOI:10.1002/14651858.CD000553.pub2, PMID 17054131.
(EN) Saab S, Nieto JM, Lewis SK, Runyon BA, TIPS versus paracentesis for cirrhotic patients with refractory ascites, in Sammy Saab (a cura di), TIPSS versus paracentesis for cirrhotic patients with refractory ascites, Cochrane Database Syst Rev, n. 4, 2006, pp. CD004889, DOI:10.1002/14651858.CD004889.pub2, PMID 17054221.
(EN) Ryan JM, Shawcross DL, Hepatic encephalopathy, in Medicine, vol. 39, n. 10, 2011, pp. 617–620, DOI:10.1016/j.mpmed.2011.07.008.
(EN) Butterworth RF, Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities, in J. Steroid Biochem. Mol. Biol., vol. 160, giugno 2016, pp. 94–7, DOI:10.1016/j.jsbmb.2015.11.006, PMID 26589093.
(EN) Butterworth RF, Hepatic encephalopathy in alcoholic cirrhosis, in Handb Clin Neurol, vol. 125, 2014, pp. 589–602, DOI:10.1016/B978-0-444-62619-6.00034-3, PMID 25307598.
(EN) Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R, Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, in Hepatology, vol. 45, n. 3, 2007, pp. 549-59, DOI:10.1002/hep.21533, PMID 17326150.
(EN) Randolph C, Hilsabeck R, Kato A, et al., Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines, in Liver Int., vol. 29, n. 5, maggio 2009, pp. 629–35, DOI:10.1111/j.1478-3231.2009.02009.x, PMID 19302444. URL consultato il 2 novembre 2013 (archiviato dall'url originale il 10 dicembre 2012).
(EN) Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI, Current concepts in the assessment and treatment of hepatic encephalopathy, in QJM, vol. 103, n. 1, gennaio 2010, pp. 9–16, DOI:10.1093/qjmed/hcp152, PMID 19903725.
(EN) Weissenborn K, Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles, in Drugs, vol. 79, Suppl 1, febbraio 2019, pp. 5–9, DOI:10.1007/s40265-018-1018-z, PMC 6416238, PMID 30706420.
(EN) Randolph C, Tierney MC, Mohr E, Chase TN, The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity, in J Clin Exp Neuropsychol, vol. 20, n. 3, giugno 1998, pp. 310–9, DOI:10.1076/jcen.20.3.310.823, PMID 9845158.
(EN) Als-Nielsen B, Gluud L, Gluud C, Nonabsorbable disaccharides for hepatic encephalopathy, in Bodil Als-Nielsen (a cura di), Cochrane Database of Systematic Reviews, Cochrane Database Syst Rev, n. 2, 2004, pp. CD003044, DOI:10.1002/14651858.CD003044.pub2, PMID 15106187.
(EN) Shalimar, Acharya SK, Management in acute liver failure, in J Clin Exp Hepatol, vol. 5, Suppl 1, marzo 2015, pp. S104–15, DOI:10.1016/j.jceh.2014.11.005, PMC 4442864, PMID 26041950.
(EN) Hadjihambi A, Arias N, Sheikh M, Jalan R, Hepatic encephalopathy: a critical current review, in Hepatol Int, vol. 12, Suppl 1, febbraio 2018, pp. 135–147, DOI:10.1007/s12072-017-9812-3, PMC 5830466, PMID 28770516.
(EN) Bunchorntavakul C, Reddy KR, Acute Liver Failure, in Clin Liver Dis, vol. 21, n. 4, novembre 2017, pp. 769–792, DOI:10.1016/j.cld.2017.06.002, PMID 28987262.

gastrojournal.org

(EN) Conn HO, Leevy CM, Vlahcevic ZR, et al., Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial, in Gastroenterology, vol. 72, 4 Pt 1, 1977, pp. 573–83, PMID 14049.

gov.

ncbi.nlm.nih.gov.

(EN) Saab S, Nieto JM, Lewis SK, Runyon BA, TIPS versus paracentesis for cirrhotic patients with refractory ascites, in Sammy Saab (a cura di), TIPSS versus paracentesis for cirrhotic patients with refractory ascites, Cochrane Database Syst Rev, n. 4, 2006, pp. CD004889, DOI:10.1002/14651858.CD004889.pub2, PMID 17054221.

jhep-elsevier.com

(EN) Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H, Neuropsychological characterization of hepatic encephalopathy, in J. Hepatol., vol. 34, n. 5, maggio 2001, pp. 768–73, DOI:10.1016/S0168-8278(01)00026-5, PMID 11434627.

nih.gov

ncbi.nlm.nih.gov

(EN) Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI, Current concepts in the assessment and treatment of hepatic encephalopathy, in QJM, vol. 103, n. 1, gennaio 2010, pp. 9–16, DOI:10.1093/qjmed/hcp152, PMID 19903725.
(EN) Polson J, Lee WM, AASLD position paper: the management of acute liver failure, in Hepatology, vol. 41, n. 5, maggio 2005, pp. 1179–97, DOI:10.1002/hep.20703, PMID 15841455. URL consultato il 2 novembre 2013 (archiviato dall'url originale il 16 dicembre 2012).
(EN) Bajaj JS, Review article: the modern management of hepatic encephalopathy, in Aliment. Pharmacol. Ther., vol. 31, n. 5, marzo 2010, pp. 537–47, DOI:10.1111/j.1365-2036.2009.04211.x, PMID 20002027.
(EN) Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H, Neuropsychological characterization of hepatic encephalopathy, in J. Hepatol., vol. 34, n. 5, maggio 2001, pp. 768–73, DOI:10.1016/S0168-8278(01)00026-5, PMID 11434627.
(EN) Summerskill WH, Davidson EA, Sherlock S, Steiner RE, The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation, in Q. J. Med., vol. 25, n. 98, aprile 1956, pp. 245–66, PMID 13323252.
(EN) Sherlock S, Summerskill WH, White LP, Phear EA, Portal-systemic encephalopathy; neurological complications of liver disease, in Lancet, vol. 264, n. 6836, settembre 1954, pp. 453–7, DOI:10.1016/S0140-6736(54)91874-7, PMID 13193045.
(EN) Last PM, Sherlock S, Systemic absorption of orally administered neomycin in liver disease, in N. Engl. J. Med., vol. 262, n. 8, febbraio 1960, pp. 385–9, DOI:10.1056/NEJM196002252620803, PMID 14414396.
(EN) Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A, Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998, in Hepatology, vol. 35, n. 3, 2002, pp. 716–21, DOI:10.1053/jhep.2002.31250, PMID 11870389.
(EN) Conn HO, Leevy CM, Vlahcevic ZR, et al., Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial, in Gastroenterology, vol. 72, 4 Pt 1, 1977, pp. 573–83, PMID 14049.
(EN) Sundaram V, Shaikh OS, Hepatic encephalopathy: pathophysiology and emerging therapies, in Med. Clin. North Am., vol. 93, n. 4, luglio 2009, pp. 819–36, vii, DOI:10.1016/j.mcna.2009.03.009, PMID 19577116.
(EN) Khan S, Tudur Smith C, Williamson P, Sutton R, Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis, in Saboor A Khan (a cura di), Cochrane Database of Systematic Reviews, Cochrane Database Syst Rev, n. 4, 2006, pp. CD000553, DOI:10.1002/14651858.CD000553.pub2, PMID 17054131.
(EN) Saab S, Nieto JM, Lewis SK, Runyon BA, TIPS versus paracentesis for cirrhotic patients with refractory ascites, in Sammy Saab (a cura di), TIPSS versus paracentesis for cirrhotic patients with refractory ascites, Cochrane Database Syst Rev, n. 4, 2006, pp. CD004889, DOI:10.1002/14651858.CD004889.pub2, PMID 17054221.
(EN) Butterworth RF, Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities, in J. Steroid Biochem. Mol. Biol., vol. 160, giugno 2016, pp. 94–7, DOI:10.1016/j.jsbmb.2015.11.006, PMID 26589093.
(EN) Butterworth RF, Hepatic encephalopathy in alcoholic cirrhosis, in Handb Clin Neurol, vol. 125, 2014, pp. 589–602, DOI:10.1016/B978-0-444-62619-6.00034-3, PMID 25307598.
(EN) Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL, Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial, in Gastroenterology, vol. 72, 4 Pt 1, 1977, pp. 573–83, PMID 14049.
(EN) Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R, Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, in Hepatology, vol. 45, n. 3, 2007, pp. 549-59, DOI:10.1002/hep.21533, PMID 17326150.
(EN) Randolph C, Hilsabeck R, Kato A, et al., Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines, in Liver Int., vol. 29, n. 5, maggio 2009, pp. 629–35, DOI:10.1111/j.1478-3231.2009.02009.x, PMID 19302444. URL consultato il 2 novembre 2013 (archiviato dall'url originale il 10 dicembre 2012).
(EN) Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI, Current concepts in the assessment and treatment of hepatic encephalopathy, in QJM, vol. 103, n. 1, gennaio 2010, pp. 9–16, DOI:10.1093/qjmed/hcp152, PMID 19903725.
(EN) Weissenborn K, Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles, in Drugs, vol. 79, Suppl 1, febbraio 2019, pp. 5–9, DOI:10.1007/s40265-018-1018-z, PMC 6416238, PMID 30706420.
(EN) Randolph C, Tierney MC, Mohr E, Chase TN, The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity, in J Clin Exp Neuropsychol, vol. 20, n. 3, giugno 1998, pp. 310–9, DOI:10.1076/jcen.20.3.310.823, PMID 9845158.
(EN) Als-Nielsen B, Gluud L, Gluud C, Nonabsorbable disaccharides for hepatic encephalopathy, in Bodil Als-Nielsen (a cura di), Cochrane Database of Systematic Reviews, Cochrane Database Syst Rev, n. 2, 2004, pp. CD003044, DOI:10.1002/14651858.CD003044.pub2, PMID 15106187.
(EN) Shalimar, Acharya SK, Management in acute liver failure, in J Clin Exp Hepatol, vol. 5, Suppl 1, marzo 2015, pp. S104–15, DOI:10.1016/j.jceh.2014.11.005, PMC 4442864, PMID 26041950.
(EN) Hadjihambi A, Arias N, Sheikh M, Jalan R, Hepatic encephalopathy: a critical current review, in Hepatol Int, vol. 12, Suppl 1, febbraio 2018, pp. 135–147, DOI:10.1007/s12072-017-9812-3, PMC 5830466, PMID 28770516.
(EN) Bunchorntavakul C, Reddy KR, Acute Liver Failure, in Clin Liver Dis, vol. 21, n. 4, novembre 2017, pp. 769–792, DOI:10.1016/j.cld.2017.06.002, PMID 28987262.

oadoi.org

(EN) Bajaj JS, Review article: the modern management of hepatic encephalopathy, in Aliment. Pharmacol. Ther., vol. 31, n. 5, marzo 2010, pp. 537–47, DOI:10.1111/j.1365-2036.2009.04211.x, PMID 20002027.
(EN) Sherlock S, Summerskill WH, White LP, Phear EA, Portal-systemic encephalopathy; neurological complications of liver disease, in Lancet, vol. 264, n. 6836, settembre 1954, pp. 453–7, DOI:10.1016/S0140-6736(54)91874-7, PMID 13193045.
(EN) Last PM, Sherlock S, Systemic absorption of orally administered neomycin in liver disease, in N. Engl. J. Med., vol. 262, n. 8, febbraio 1960, pp. 385–9, DOI:10.1056/NEJM196002252620803, PMID 14414396.
(EN) Ryan JM, Shawcross DL, Hepatic encephalopathy, in Medicine, vol. 39, n. 10, 2011, pp. 617–620, DOI:10.1016/j.mpmed.2011.07.008.
(EN) Butterworth RF, Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities, in J. Steroid Biochem. Mol. Biol., vol. 160, giugno 2016, pp. 94–7, DOI:10.1016/j.jsbmb.2015.11.006, PMID 26589093.
(EN) Butterworth RF, Hepatic encephalopathy in alcoholic cirrhosis, in Handb Clin Neurol, vol. 125, 2014, pp. 589–602, DOI:10.1016/B978-0-444-62619-6.00034-3, PMID 25307598.
(EN) Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI, Current concepts in the assessment and treatment of hepatic encephalopathy, in QJM, vol. 103, n. 1, gennaio 2010, pp. 9–16, DOI:10.1093/qjmed/hcp152, PMID 19903725.
(EN) Randolph C, Tierney MC, Mohr E, Chase TN, The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity, in J Clin Exp Neuropsychol, vol. 20, n. 3, giugno 1998, pp. 310–9, DOI:10.1076/jcen.20.3.310.823, PMID 9845158.
(EN) Bunchorntavakul C, Reddy KR, Acute Liver Failure, in Clin Liver Dis, vol. 21, n. 4, novembre 2017, pp. 769–792, DOI:10.1016/j.cld.2017.06.002, PMID 28987262.

wiley.com

aasldpubs.onlinelibrary.wiley.com

(EN) Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A, Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998, in Hepatology, vol. 35, n. 3, 2002, pp. 716–21, DOI:10.1053/jhep.2002.31250, PMID 11870389.